Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Seminars in Oncology
|
May 13, 2015
PD-L1 inhibition with MPDL3280A for solid tumors
Edward Cha, Jeffrey Wallin, Marcin Kowanetz
Viruses
|
March 6, 2021
Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes
Minchao Li, Jinfeng Zeng, Ruiting Li, et al.
Bioanalysis
|
October 8, 2016
Fit-for-purpose biomarker immunoassay qualification and validation: three case studies
Kyra Cowan, Xiaoying Gao, Vaishali Parab, et al.
Proteomics
|
June 9, 2016
Phosphoproteome analysis of the MAPK pathway reveals previously undetected feedback mechanisms
Florian Gnad, Sophia Doll, Kyung Song, et al.
Proteomics
|
June 11, 2016
Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network
Florian Gnad, Jeffrey Wallin, Kyle Edgar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 28, 2018
Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer
Stephen V Liu, D Ross Camidge, Scott N Gettinger, et al.
JHEP Reports : Innovation in Hepatology
|
December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection
Nicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR
Timothy P Heffron, Chudi O Ndubaku, Laurent Salphati, et al.
Journal of Medicinal Chemistry
|
September 6, 2012
The design and identification of brain penetrant inhibitors of phosphoinositide 3-kinase α
Timothy P Heffron, Laurent Salphati, Bruno Alicke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2020
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1
Sharon A Riddler, Michael Para, Constance A Benson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Seminars in Oncology
|
May 13, 2015
PD-L1 inhibition with MPDL3280A for solid tumors
Edward Cha, Jeffrey Wallin, Marcin Kowanetz
Viruses
|
March 6, 2021
Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes
Minchao Li, Jinfeng Zeng, Ruiting Li, et al.
Bioanalysis
|
October 8, 2016
Fit-for-purpose biomarker immunoassay qualification and validation: three case studies
Kyra Cowan, Xiaoying Gao, Vaishali Parab, et al.
Proteomics
|
June 9, 2016
Phosphoproteome analysis of the MAPK pathway reveals previously undetected feedback mechanisms
Florian Gnad, Sophia Doll, Kyung Song, et al.
Proteomics
|
June 11, 2016
Quantitative phosphoproteomic analysis of the PI3K-regulated signaling network
Florian Gnad, Jeffrey Wallin, Kyle Edgar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 28, 2018
Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer
Stephen V Liu, D Ross Camidge, Scott N Gettinger, et al.
JHEP Reports : Innovation in Hepatology
|
December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection
Nicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR
Timothy P Heffron, Chudi O Ndubaku, Laurent Salphati, et al.
Journal of Medicinal Chemistry
|
September 6, 2012
The design and identification of brain penetrant inhibitors of phosphoinositide 3-kinase α
Timothy P Heffron, Laurent Salphati, Bruno Alicke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2020
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1
Sharon A Riddler, Michael Para, Constance A Benson, et al.
Page
of 2